Internal Medicine, Gastroenterology · San Angelo, TX
NPI
1487635066
Since 2005
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4450 Sunset Drive
San Angelo, TX, 76904
Phone (325) 658-1511
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
1,499 services
Medicare patients, 2024
829
Average age 74
Drug cost, 2024
$1.6M
3,412 prescriptions
Company payments, 2025
$1,315
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen W Coates was code 99213 (office e&m - established), 215 times for 198 patients. In total Stephen W Coates billed 1,499 services in 44 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 215 | 198 | $64.13 | $14K |
| 45380 Lower GI Endoscopy - Other | Office | 197 | 196 | $124.11 | $24K |
| 43239 Upper GI Endoscopy | Office | 149 | 145 | $66.59 | $9,922 |
| 36415 Venipuncture Blood Collection | Office | 138 | 106 | $7.79 | $1,075 |
| 43239 Upper GI Endoscopy | Facility | 113 | 105 | $64.37 | $7,274 |
| 99214 Office E&M - Established | Office | 104 | 81 | $85.34 | $8,875 |
| 45385 Colonoscopy - Lesion Removal | Office | 90 | 89 | $215.56 | $19K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Office | 55 | 55 | $180.72 | $9,939 |
| 43249 Upper GI Endoscopy | Office | 54 | 53 | $99.60 | $5,378 |
| 45380 Lower GI Endoscopy - Other | Facility | 48 | 48 | $110.08 | $5,284 |
| 43249 Upper GI Endoscopy | Facility | 42 | 41 | $106.63 | $4,478 |
| 45385 Colonoscopy - Lesion Removal | Facility | 34 | 33 | $211.78 | $7,200 |
| 99204 Office E&M - New | Office | 33 | 33 | $128.09 | $4,227 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 27 | 26 | $180.53 | $4,874 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 25 | 25 | $182.01 | $4,550 |
By year: 2022 $135K for 1,517 services; 2023 $127K for 1,389 services; 2024 $145K for 1,499 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 138 | 106 | $7.79 | $1,075 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen W Coates prescribed most often to Medicare patients was Omeprazole, with 590 prescriptions and refills. In total Stephen W Coates wrote 3,412 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 590 | 1,571 | 194 | $8,199 |
| Pantoprazole Sodium Generic | 362 | 988 | 111 | $6,460 |
| Famotidine Generic | 288 | 768 | 104 | $3,897 |
| Esomeprazole Magnesium Generic | 244 | 665 | 84 | $12K |
| Peg3350-Sod Sul-Nacl-Kcl-Asb-C Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 222 | 222 | 219 | $13K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 179 | 179 | 179 | $11K |
| Mirtazapine Generic | 91 | 119 | 26 | $969 |
| Linzess Linaclotide | 80 | 142 | 24 | $70K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 73 | 73 | 26 | $2,685 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 73 | 73 | 72 | $10K |
| Ondansetron Odt Ondansetron | 67 | 68 | 34 | $980 |
| Lubiprostone Generic | 55 | 77 | 12 | $6,120 |
| Sucralfate Generic | 52 | 60 | 32 | $2,424 |
| Dexlansoprazole Dr Dexlansoprazole | 52 | 118 | 13 | $19K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 51 | 51 | 51 | $8,730 |
Brand drugs: - claims; generic drugs: 2,639 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen W Coates $1,315 ($1,315 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $679.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 42 | $679 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $147 |
| Madrigal Pharmaceuticals MDGL | 6 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $131 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $75.41 |
| QOL Medical, LLC | 1 | $38.31 |
| Gilead Sciences, Inc. GILD | 2 | $34.64 |
| Ardelyx, Inc. ARDX | 2 | $31.29 |
| Aimmune Therapeutics, Inc. | 1 | $21.05 |
| Ferring Pharmaceuticals Inc. | 1 | $17.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.